PLoS One:天然药物补骨脂素能定向攻击HER2阳性乳腺癌细胞

2014-03-02 MedSci MedSci原创

近日,Duke大学研究人员报告称:一种常见的已知能对抗淋巴癌和皮肤疾病的化合物也能对某些恶性程度的乳房肿瘤有潜在治疗作用。该化合物被称为补骨脂素,是在无花果以及芹菜中发现的天然组分,研究人员早已了解,它的工作原理是通过破坏DNA的复制和引起的细胞死亡,但其发挥功效需要获得一个能量源,例如紫外光激活补骨脂素后才能使其发挥作用。现在杜克大学的研究人员已经确定了化合物杀死肿瘤细胞的另一种方式,这便于发展


近日,Duke大学研究人员报告称:一种常见的已知能对抗淋巴癌和皮肤疾病的化合物也能对某些恶性程度的乳房肿瘤有潜在治疗作用。该化合物被称为补骨脂素,是在无花果以及芹菜中发现的天然组分,研究人员早已了解,它的工作原理是通过破坏DNA的复制和引起的细胞死亡,但其发挥功效需要获得一个能量源,例如紫外光激活补骨脂素后才能使其发挥作用。

现在杜克大学的研究人员已经确定了化合物杀死肿瘤细胞的另一种方式,这便于发展补骨脂素为一种有效的癌症治疗药物。相关研究论文发表在2014年2月14日的PLOS ONE期刊上,研究人员详细汇报了补骨脂素如何阻断HER2受体,HER2受体是在乳腺癌、卵巢癌胃癌等实体瘤过多表达的信号通路。
当HER2生产过剩,它促使细胞生长失控,导致癌症更具侵略性。在实验中,补骨脂素关闭HER2过表达乳腺癌细胞系的该过程。Neil L. Spector医学博士说:这是非常意外的,虽然已经知道补骨脂素通过引起DNA损伤来杀死癌细胞,但它对HER2过度表达乳腺癌细胞的直接抗肿瘤作用通
过阻断HER2信号来实现的。

补骨脂素还攻击另一种形式的HER2,即存在于肿瘤细胞细胞核中的HER2。这种形式的HER2蛋白是癌细胞抗癌症疗法的主要原因之一。当HER2受体处于细胞的外部,癌症药物能够识别HER2受体,但药物不能识别的细胞核内的HER2受体,Spector说:williamhill asia 已经表明,补骨脂素能有效地瞄准这个形式的HER2,改善耐药性。

原始出处:

Xia W, Gooden D, Liu L, Zhao S, Soderblom EJ, Toone EJ, Beyer WF Jr, Walder H, Spector NL.Photo-Activated Psoralen Binds the ErbB2 Catalytic Kinase Domain, Blocking ErbB2 Signaling and Triggering Tumor Cell Apoptosis.PLoS One. 2014 Feb 14;9(2):e88983.

相关文献:
Wu C, Sun Z, Ye Y, Han X, Song X, Liu S.Psoralen inhibits bone metastasis of breast cancer in mice.Fitoterapia. 2013 Dec;91:205-10.

Xin D, Wang H, Yang J, Su YF, Fan GW, Wang YF, Zhu Y, Gao XM.Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity.Phytomedicine. 2010 Feb;17(2):126-31

小知识:
ErbB2(又名ErbB2, NEU, CD340)是原癌基因erbB-2编码的185kDa的细胞膜受体,为表皮生长因子受体(epidermalgrowthfactorreceptor,EGFR)家族 成员之一。该家族包括ErbB-1(又称EGFR,HER1)、ErbB2(又称HER2)、ErbB-3(HER3)和ErbB-4(HER4)四个成员。


ErbB2高表达肿瘤细胞中Ras-MAPK和PI3K-Akt信号传导活性较高,细胞增殖能力较强,分化成熟和凋亡机制受到抑制,细胞恶性程度高。

ErbB2高表达肿瘤细胞可抵抗TNF-α、射线以及各种化疗药物引起的细胞凋亡效应。
临床上ErbB2表达与患者预后密切相关,ErbB2高表达的患者易发生肿瘤转移,存活期短。由于ErbB2在正常 细胞和肿瘤细胞中的表达水平具有显著的差异,因而已成为肿瘤免疫生物治疗的理想靶点,亦是目前肿瘤治疗研究领域的热点分子。Herstatin是近年来发 现的唯一天然存在的ErbB2自身抑制分子,它是ErbB2mRNA加工过程中选择性剪接的产物,是一种可溶性的ErbB2受体。

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1768980, encodeId=1f001e6898068, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Tue Apr 29 15:16:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754512, encodeId=53551e54512a4, content=<a href='/topic/show?id=60e1441e10c' target=_blank style='color:#2F92EE;'>#天然药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44171, encryptionId=60e1441e10c, topicName=天然药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Nov 10 12:16:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789575, encodeId=954f1e89575aa, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Jan 25 20:16:00 CST 2015, time=2015-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8114, encodeId=7904811480, content=补骨脂素对机体正常细胞细胞的独立研究应该进一步研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7d97632, createdName=guolihui123, createdTime=Wed Mar 05 21:39:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251968, encodeId=6c4412519684f, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308463, encodeId=899b1308463a2, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=)]
    2014-04-29 liao1632
  2. [GetPortalCommentsPageByObjectIdResponse(id=1768980, encodeId=1f001e6898068, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Tue Apr 29 15:16:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754512, encodeId=53551e54512a4, content=<a href='/topic/show?id=60e1441e10c' target=_blank style='color:#2F92EE;'>#天然药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44171, encryptionId=60e1441e10c, topicName=天然药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Nov 10 12:16:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789575, encodeId=954f1e89575aa, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Jan 25 20:16:00 CST 2015, time=2015-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8114, encodeId=7904811480, content=补骨脂素对机体正常细胞细胞的独立研究应该进一步研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7d97632, createdName=guolihui123, createdTime=Wed Mar 05 21:39:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251968, encodeId=6c4412519684f, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308463, encodeId=899b1308463a2, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1768980, encodeId=1f001e6898068, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Tue Apr 29 15:16:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754512, encodeId=53551e54512a4, content=<a href='/topic/show?id=60e1441e10c' target=_blank style='color:#2F92EE;'>#天然药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44171, encryptionId=60e1441e10c, topicName=天然药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Nov 10 12:16:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789575, encodeId=954f1e89575aa, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Jan 25 20:16:00 CST 2015, time=2015-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8114, encodeId=7904811480, content=补骨脂素对机体正常细胞细胞的独立研究应该进一步研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7d97632, createdName=guolihui123, createdTime=Wed Mar 05 21:39:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251968, encodeId=6c4412519684f, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308463, encodeId=899b1308463a2, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1768980, encodeId=1f001e6898068, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Tue Apr 29 15:16:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754512, encodeId=53551e54512a4, content=<a href='/topic/show?id=60e1441e10c' target=_blank style='color:#2F92EE;'>#天然药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44171, encryptionId=60e1441e10c, topicName=天然药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Nov 10 12:16:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789575, encodeId=954f1e89575aa, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Jan 25 20:16:00 CST 2015, time=2015-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8114, encodeId=7904811480, content=补骨脂素对机体正常细胞细胞的独立研究应该进一步研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7d97632, createdName=guolihui123, createdTime=Wed Mar 05 21:39:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251968, encodeId=6c4412519684f, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308463, encodeId=899b1308463a2, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=)]
    2014-03-05 guolihui123

    补骨脂素对机体正常细胞细胞的独立研究应该进一步研究

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1768980, encodeId=1f001e6898068, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Tue Apr 29 15:16:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754512, encodeId=53551e54512a4, content=<a href='/topic/show?id=60e1441e10c' target=_blank style='color:#2F92EE;'>#天然药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44171, encryptionId=60e1441e10c, topicName=天然药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Nov 10 12:16:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789575, encodeId=954f1e89575aa, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Jan 25 20:16:00 CST 2015, time=2015-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8114, encodeId=7904811480, content=补骨脂素对机体正常细胞细胞的独立研究应该进一步研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7d97632, createdName=guolihui123, createdTime=Wed Mar 05 21:39:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251968, encodeId=6c4412519684f, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308463, encodeId=899b1308463a2, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=)]
    2014-03-04 yxch36
  6. [GetPortalCommentsPageByObjectIdResponse(id=1768980, encodeId=1f001e6898068, content=<a href='/topic/show?id=d7674593e05' target=_blank style='color:#2F92EE;'>#定向#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45937, encryptionId=d7674593e05, topicName=定向)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920637977772, createdName=liao1632, createdTime=Tue Apr 29 15:16:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754512, encodeId=53551e54512a4, content=<a href='/topic/show?id=60e1441e10c' target=_blank style='color:#2F92EE;'>#天然药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44171, encryptionId=60e1441e10c, topicName=天然药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Nov 10 12:16:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789575, encodeId=954f1e89575aa, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Jan 25 20:16:00 CST 2015, time=2015-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=8114, encodeId=7904811480, content=补骨脂素对机体正常细胞细胞的独立研究应该进一步研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7d97632, createdName=guolihui123, createdTime=Wed Mar 05 21:39:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251968, encodeId=6c4412519684f, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308463, encodeId=899b1308463a2, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Tue Mar 04 14:16:00 CST 2014, time=2014-03-04, status=1, ipAttribution=)]

相关威廉亚洲官网

Cancer:吸烟致女性患乳腺癌风险增加

近日,发表在Cancer杂志上的一项新研究揭示:吸烟,并且十年以上一天吸一包烟的年轻女性患最常见类型乳腺癌的风险显著增加。【原文下载】 研究表明,年轻女性吸烟的另一个健康风险可能是乳腺癌的危险性增加。 大多数最近的研究评估吸烟与年轻女性乳腺癌风险之间的关系,发现吸烟与风险的增加联系在一起,然而,很少有研究评估吸烟对乳腺癌的不同亚型风险的影响。 Christopher Li博士和他的同事进行了

ONCOLOGY:乳腺癌内分泌辅助治疗5年足矣?

在2013年12月份的ONCOLOGY在线期刊上,发表了匹兹堡大学大学癌症研究所Rachel Jankowitz教授和UPMC癌症中心Nancy Davidson教授的一篇论文,文章讨论了对于早期乳腺癌患者内分泌治疗应该持续多长时间的问题。对于这一问题,Jankowitz教授和Davidson教授表达了两种截然不同的观点。ONCOLOGY: Cuzick教授认为他莫西芬具有“延滞效应”,这也是

SSO-ASTRO一致意见:大手术切缘不减少同侧乳腺癌复发风险

没有证据显示与墨染处无肿瘤相比大手术切缘会额外减少同侧乳腺癌复发风险。威廉亚洲博彩公司 建议一些女性不必行手术治疗,并鼓励患者尽可能选择乳房肿瘤切除术而非全乳切除术。2013年,美国外科肿瘤学会(SSO) 及美国放疗肿瘤学会 (ASTRO) 共同组建了一个专家小组,以探讨手术切缘宽度与同侧乳腺癌复发风险之间的关系,并共同推出了一部关于 I期 和 II 期浸润性乳腺癌患者行保乳手术并全乳放疗的手术边缘威廉亚洲博彩公司 。研究者

EMBO reports:sncRNA可能是癌症的征兆

目前,癌症基因组图谱计划(The Cancer Genome Atlas,TCGA)的研究人员得出结论:小分子非编码RNA(small non-coding RNAs,sncRNAs)可以用来预测一个人是否患有乳腺癌。这项研究成果发表在2014年2月17日的国际知名杂志EMBO reports上,表明特定类型的非编码RNA的水平差异,可以用来区分癌组织和非癌组织,还可以把癌

BMJ:25年随访研究对乳腺癌X光筛查有效性提出进一步质疑

历史上规模最大、最严格细致的乳房X光检查研究之一,对所有年龄段的女性进行这种筛查的价值提出了强有力的新质疑。这项研究持续了四分之一个世纪之久,涉及9万名女性。 该研究发现,在做过乳房X线检查和没有做过它的女性中,乳腺癌导致的死亡率和所有原因导致的死亡率并无二致。而且这种筛查本身具有危害——通过乳房X光检查发现并进行了治疗的癌症肿块中,有五分之一对女性的健康并不构成威胁,也不需要进行化

JCI:研究发现治疗乳腺癌的新靶标

乳腺癌是女性最常见的癌症,乳腺癌患者是激素依赖性的,目前的治疗重点是利用药物,阻断雌激素(一种激素)附着于肿瘤细胞上的雌激素对受体,防止癌细胞生长和扩散。【原文下载】 在一项新研究中,Sandro Santagata博士以及一组研究人员发现,还有其他的受体(雄激素和维生素D受体),可以有针对性的靶向治疗乳腺癌。 这些发现可能会改变williamhill asia 如何治疗乳腺癌,Santagata说,由于至少有50%乳腺癌